Navigation Links
Cardiogenesis Reports Third Quarter 2009 Results
Date:11/10/2009

IRVINE, Calif., Nov. 10 /PRNewswire-FirstCall/ -- Cardiogenesis Corporation (Pink Sheets: CGCP), a leading developer of surgical products used in the treatment of patients suffering from severe angina, today reported financial results for its third quarter ended September 30, 2009.

Net revenues in the third quarter of 2009 totaled $2,134,000 an 18% decrease from prior year third quarter net revenues of $2,618,000. The decrease in sales was primarily attributed to the absence of laser sales during the three month period ended September 30, 2009 as compared to laser sales of $373,000 for the three months ended September 30, 2008.

Net revenues in the first nine months of 2009 totaled $7,222,000, a 26% decrease from net revenues of $9,719,000 in the first nine months of 2008. Laser sales decreased $1,832,000 and handpiece sales decreased $786,000 as compared to the prior year nine month period.

"We continue to make progress in our efforts to re-engage the cardiology community and to refocus our sales force on utilization of previously installed lasers. We are taking the right steps to increase our core TMR business," said Paul McCormick, Executive Chairman. He continued, "At the same time we are stepping up our investment in research and development as we prepare to initiate a U.S. clinical trial for our PHOENIX(TM) Combination Delivery System, which permits the intramyocardial delivery of both TMR and stem cells. Based upon our recent meeting with the FDA we expect to make our IDE submission by the end of the year."

The Company reported a third quarter 2009 operating loss of $718,000 as compared with an operating loss of $310,000 in the prior year quarter. The net loss for the quarter was $739,000 or $0.02 per basic and diluted share, as compared with net loss of $308,000, or $0.01 per basic and diluted share in the 2008 third quarter.

For the first nine months of 2009, Cardiogenesis reported an oper
'/>"/>

SOURCE Cardiogenesis Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Cardiogenesis Announces Presentation of its PHOENIX(R) Combination TMR Plus Stem Cell Delivery System at the International Society of Minimally Invasive Cardiothoracic Surgeons (ISMICS) Annual Meeting
2. Cardiogenesis Announces Preliminary Clinical Results With the PHOENIX System Combining TMR + Stem Cells
3. Vion Pharmaceuticals Reports 2009 Third Quarter and Nine-Month Results
4. PLC Systems Reports Third Quarter 2009 Results; Announces Distribution Agreement for RenalGuard(R) in Brazil
5. Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results
6. SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results
7. Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results
8. Osteotech Reports Third Quarter 2009 Financial Results
9. Air Methods Reports 3Q2009 Results and 4Q2009 Update
10. Genoptix Reports Continued Strong Growth for the Third Quarter and First Nine Months of 2009
11. InterMune Reports Third Quarter 2009 Financial Results and Business Highlights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)...  Today, the National Patient Advocate Foundation acknowledges that ... Representatives recently approved a bill that would prohibit insurers ... out-of-pocket fees for newer, more expensive oral anti-cancer drugs ... severe side-effects. However, the bill was amended to include ... to be a barrier to patients with cancer and ...
(Date:5/16/2013)... 16, 2013  Amgen (NASDAQ: AMGN ) will ... May 21, 2013, at the Sheraton New York Times Square ... 10:00 a.m. Eastern Daylight Time. Joseph P. Miletich ... Development at Amgen, will present at the conference. Live audio ... on Amgen,s website, www.amgen.com , under Investors. A replay ...
(Date:5/16/2013)... 16, 2013  ULURU Inc. (OTCQB: ULUR) today announced its ... and provided a review of its operating activities. ... the previously communicated outlook for 2013: , Launching Altrazeal ... network of distribution partners to cover all major markets excluding ... ® to be marketed in approximately 50 markets by ...
Breaking Medicine Technology:National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 2National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 3ULURU Inc. Reports First Quarter 2013 Financial Results 2ULURU Inc. Reports First Quarter 2013 Financial Results 3ULURU Inc. Reports First Quarter 2013 Financial Results 4ULURU Inc. Reports First Quarter 2013 Financial Results 5
... , , HONG KONG, ... world,s first pro-healing stent, OrbusNeich,s Genous Bio-engineered R stent, and ... presented next week at the Transcatheter Cardiovascular Therapeutics symposium, TCT ... de Winter, M.D., Ph.D., of the Academic Medical Center in ...
... , SAN DIEGO, Sept. 14 Optimer ... presentation of results from its second prulifloxacin Phase 3 clinical ... clinical investigator Robert Steffen, M.D., at the annual Interscience Conference ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20090413/LA97352LOGO ) , ...
Cached Medicine Technology:Data From Multiple Clinical Trials of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented at TCT 2009 2Data From Multiple Clinical Trials of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented at TCT 2009 3Data From Optimer's Second Phase 3 Study of Prulifloxacin Presented at Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) 2Data From Optimer's Second Phase 3 Study of Prulifloxacin Presented at Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) 3Data From Optimer's Second Phase 3 Study of Prulifloxacin Presented at Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) 4Data From Optimer's Second Phase 3 Study of Prulifloxacin Presented at Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) 5
(Date:5/18/2013)... Dr. Robert Tracey, an area leader in dental laser ... of the root causes of sleep apnea to provide and ... Sleep Month, Dr. Tracey points out estimates revealing that 40 ... sleep apnea is one of the most common of all. ... breathing at different times while sleeping. When this happens, the ...
(Date:5/18/2013)... John Ravera, D.D.S., a Newport Beach cosmetic dentist ... to his dental team, Courtney Marino. , Marino is a ... 10 years. She received her degree from West Coast University, ... of Sigma Pi Alpha, a national honor society for individuals ... of all ages, helping them understand the importance of preventing ...
(Date:5/18/2013)... According to the the Stevens Johnson Syndrome Foundation, ... is a severe allergic reaction usually to medicine (i). ... can quickly advance causing blistering and large areas of dead ... SJS can develop at any time and seriously affect both ... Manute Bol, passed away after he received kidney medicine which ...
(Date:5/18/2013)... The product liability attorneys at Wright & Schulte ... consumers nationwide who have sustained serious tendon injuries allegedly caused ... are all part of MDL 2308 and were all filed ... be heard in the U.S. District Court of the Western ... LLC specializes in defending the rights of those who have ...
(Date:5/17/2013)... 2013 Daily Gossip announced on Monday that ... of the Program Yourself Thin regime, Jim Katsoulis. ... website by the end of the month in order to ... reeducate themselves and lead a healthy lifestyle, free of food ... package is available for only $97 and it comes ...
Breaking Medicine News(10 mins):Health News:Pomona, NY Dentist, Dr. Robert Tracey of General & Laser Assisted Dentistry (GLAD) Highlights Sleep Apnea Dentistry Services for Better Sleep Month 2Health News:Pomona, NY Dentist, Dr. Robert Tracey of General & Laser Assisted Dentistry (GLAD) Highlights Sleep Apnea Dentistry Services for Better Sleep Month 3Health News:Newport Beach Cosmetic Dentist John Ravera Adds New Member to Dental Team 2Health News:Injury Law Firm Announces New Informative Graphic on Common Medicines That Have Allegedly Been Linked to Stevens Johnson Syndrome 2Health News:Ten Skechers Lawsuits Filed by Wright & Schulte on Behalf of Consumers Who Sustained Severe Tendon Damage Allegedly Due to Wearing Skechers Shape-Ups 2Health News:Ten Skechers Lawsuits Filed by Wright & Schulte on Behalf of Consumers Who Sustained Severe Tendon Damage Allegedly Due to Wearing Skechers Shape-Ups 3Health News:Ten Skechers Lawsuits Filed by Wright & Schulte on Behalf of Consumers Who Sustained Severe Tendon Damage Allegedly Due to Wearing Skechers Shape-Ups 4Health News:Program Yourself Thin Review and Secrets Revealed By Daily Gossip Magazine 2
... men are more at risk of diseases caused by blood ... of diseases caused by the inappropriate formation of a blood ... and stroke, but the reasons for this are not completely ... California, San Francisco, have used a mouse model of thrombosis ...
... review of 11 anti-seizure drugs that showed double the ... Anti-seizure drugs can cause increased suicidal tendencies in patients, ... 20-member panel of experts voted unanimously to back the ... Food and Drug Administration, the Associated Press ...
... are just a few of the extra costs that ... a new study that will be published in current ... social work at Washington University in St. Louis, found ... children,s special needs have different out-of-pocket health expenditures depending ...
... Today, PRINCETON, N.J., July 10 ... alerts and travel security,information from renowned intelligence ... http://www.securassist.com . The redesigned site, launched today, ... for preventing and,handling travel security emergencies., ...
... reported preliminary total retail drug,store sales for the 5-week, 9-week and 22-week periods ended July 3, 2008., , ... Periods ended July 3, 2008, ... Quarter Year ... to Date to Date (Dollars in millions) ...
... from UCLA and the Veterans Affairs Greater Los Angeles ... wearable artificial kidney, or AWAK, that avoids the complications ... , The design for the peritoneal-based artificial kidney ... loss and other dialysis-related problems is summarized in ...
Cached Medicine News:Health News:JCI online early table of contents: July 10, 2008 2Health News:JCI online early table of contents: July 10, 2008 3Health News:JCI online early table of contents: July 10, 2008 4Health News:JCI online early table of contents: July 10, 2008 5Health News:JCI online early table of contents: July 10, 2008 6Health News:JCI online early table of contents: July 10, 2008 7Health News:JCI online early table of contents: July 10, 2008 8Health News:Epilepsy Drugs Can Cause Suicidal Tendencies, FDA Panel Finds 2Health News:Epilepsy Drugs Can Cause Suicidal Tendencies, FDA Panel Finds 3Health News:Cost of raising a child with special needs: Where does your state rank? 2Health News:Assist America's New SecurAssist Website Features Top Travel Security Information Powered by iJET 2Health News:Longs Reports Preliminary June Retail Drug Store Sales 2Health News:Researchers design model for automated, wearable artificial kidney 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: